Literature DB >> 17997769

Two-step oblique incision during 25-gauge vitrectomy reduces incidence of postoperative hypotony.

Makoto Inoue1, Kei Shinoda, Hajime Shinoda, Ryosuke Kawamura, Kotaro Suzuki, Susumu Ishida.   

Abstract

The efficacy of a two-step, oblique incision procedure during 25-gauge vitrectomy on postoperative hypotony was evaluated by a retrospective, case-control study. The transconjunctival incision during 25-gauge vitrectomy was made in two steps: penetration with a microvitreoretinal blade followed by a penetrater instrument of a blunt trocar. The two-step procedure was performed on 89 eyes and with the conventional incision on 68 eyes. The incidence of hypotony (intraocular pressure <6 mmHg) on the first postoperative day and after 1 week and 1 month was compared. Hypotony was found in two eyes (2%) with the two-step method and 12 eyes (18%) with the conventional incision on the first postoperative day (P = 0.001, Fisher's exact probability test). The preoperative intraocular pressure was not significantly different in the two groups but was significantly higher in the two-step group than in the conventional method group on the first postoperative day (P = 0.001, Wilcoxon rank test). Twenty-five-gauge vitrectomy with two-step oblique incisions will reduce the incidence of postoperative hypotony on the first postoperative day.

Entities:  

Mesh:

Year:  2007        PMID: 17997769     DOI: 10.1111/j.1442-9071.2007.01580.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  11 in total

1.  Intraocular pressure outcomes after 23-G vitreoretinal surgery with two different transconjunctival sutureless sclerotomy techniques: vertical versus tunnel entry.

Authors:  Sevim Ayca Seyyar; Oguzhan Saygılı; Nesime Setge Tıskaoğlu
Journal:  Int Ophthalmol       Date:  2022-01-26       Impact factor: 2.031

2.  Minimally invasive vitreoretinal surgery: is sutureless vitrectomy the future of vitreoretinal surgery?

Authors:  J Fernando Arevalo; María H Berrocal; Juan D Arias; Touka Banaee
Journal:  J Ophthalmic Vis Res       Date:  2011-04

3.  Intraoperative endoscopic observation of sclerotomy site after cannula removal for 23-gauge vitrectomy.

Authors:  Taiichi Hikichi; Hirokuni Kitamei; Shoko Kosaka; Shoko Shioya; Kimitaka Takami
Journal:  Clin Ophthalmol       Date:  2014-02-28

4.  Comparison of the effects of 23-gauge and 25-gauge microincision vitrectomy blade designs on incision architecture.

Authors:  Makoto Inoue; Dina Joy K Abulon; Akito Hirakata
Journal:  Clin Ophthalmol       Date:  2014-11-19

5.  Small gauge vitrectomy: Recent update.

Authors:  Sumeet Khanduja; Ashish Kakkar; Saptrishi Majumdar; Rajpal Vohra; Satpal Garg
Journal:  Oman J Ophthalmol       Date:  2013-01

6.  In vivo comparison of 23- and 25-gauge sutureless vitrectomy incision architecture using spectral domain optical coherence tomography.

Authors:  Anderson Teixeira; Flavio A Rezende; Camila Salaroli; Nonato Souza; Benedito Antonio Sousa; Norma Allemann
Journal:  J Ophthalmol       Date:  2013-03-04       Impact factor: 1.909

7.  Favorable anatomic and visual outcomes with 25-gauge vitrectomy for myopic foveoschisis.

Authors:  Mei Mii; Masato Matsuoka; Kayako Matsuyama; Yayoi Otsu; Tetsuya Nishimura
Journal:  Clin Ophthalmol       Date:  2014-09-12

8.  Subconjunctival Injection of Viscoelastic Material for Leaking Sclerotomy in Transconjunctival Sutureless Vitrectomy.

Authors:  Chung Hyun Lee; Soo Geun Joe; Sung Jae Yang
Journal:  J Ophthalmol       Date:  2016-04-06       Impact factor: 1.909

9.  Transscleral tunnel incision related arterial hemorrhage in 23-gauge Vitrectomy: case report.

Authors:  Bingqian Liu; Yonghao Li; Tao Li; Ying Lin; Wei Ma; Lin Lu
Journal:  BMC Ophthalmol       Date:  2018-01-17       Impact factor: 2.209

Review 10.  Treatment-Emergent Adverse Events in Gene Therapy Trials for Inherited Retinal Diseases: A Narrative Review.

Authors:  Yan Nuzbrokh; Alexis S Kassotis; Sara D Ragi; Ruben Jauregui; Stephen H Tsang
Journal:  Ophthalmol Ther       Date:  2020-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.